Literaturverzeichnis

Agreus, L.; Svardsudd, K.; Talley, N. J.; Jones, M. P. und Tibblin, G. (2001): Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study, Am J Gastroenterol. 96 [10], Seite 2905-2914.

Bareiss, D.; Stabenow, R.; Muller, R.; Eisinger, B.; Stegmaier, C.; Daubler, P.; Zeitz, M. und Scherubl, H. (2002): Current epidemiology of carcinoma of the esophagus and cardia in Germany, Dtsch.Med Wochenschr. 127 [25-26], Seite 1367-1374.

Baron, T. H. und Richter, J. E. (1992): Gastroesophageal reflux disease in pregnancy, Gastroenterol.Clin.North Am 21 [4], Seite 777-791.

Bellach, B. M.; Knopf, H. und Thefeld, W. (1998): [The German Health Survey. 1997/98], Gesundheitswesen 60 Suppl 2:S59-68., Seite S59-S68.

Bollschweiler, E. und Holscher, A. H. (2000): Deutliche Zunahme des Adenokarzinoms im Ösophagus, Deutsches Ärzteblatt 97 [27], Seite 1896-1900.

Bollschweiler, E. und Holscher, A. H. (2001): Carcinoma of the esophagus--actual epidemiology in Germany, Onkologie. 24 [2], Seite 180-184.

Bour, B.; Staub, J. L.; Chousterman, M.; Labayle, D.; Nalet, B.; Nouel, O.; Pariente, A.; Tocque, E. und Bonnot-Marlier, S. (2005): Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment, Aliment Pharmacol Ther. 21 [7], Seite 805-812.

Bullinger, Kirchberger I. (1998b): Der SF-36 Fragebogen zum Gesundheitszustand. Handbuch für die deutschsprachige Fragebogenversion., Hogrefe Verlag für Psychologie., Göttingen Bern Toronto Seattle.

Bullinger, Kirchberger I. (1998c): Der SF-36 Fragebogen zum Gesundheitszustand. Handbuch für die deutschsprachige Fragebogenversion., Hogrefe Verlag für Psychologie., Göttingen Bern Toronto Seattle.

Bullinger, Kirchberger I. (1998a): Der SF-36 Fragebogen zum Gesundheitszustand. Handbuch für die deutschsprachige Fragebogenversion., Hogrefe Verlag für Psychologie., Göttingen Bern Toronto Seattle.

Bullinger, Kirchberger I. (1998d): Der SF-36 Fragebogen zum Gesundheitszustand. Handbuch für die deutschsprachige Fragebogenversion., Hogrefe Verlag für Psychologie., Göttingen Bern Toronto Seattle.

Bullinger, M. (1995b): German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment, Soc.Sci.Med 41 [10], Seite 1359-1366.

Bullinger, M. (1995c): German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment, Soc.Sci.Med 41 [10], Seite 1359-1366.

Bullinger, M. (1995a): German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment, Soc.Sci.Med 41 [10], Seite 1359-1366.

Cameron, A. J.; Zinsmeister, A. R.; Ballard, D. J. und Carney, J. A. (1990): Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings, Gastroenterology 99 [4], Seite 918-922.

Carlsson, R.; Dent, J.; Bolling-Sternevald, E.; Johnsson, F.; Junghard, O.; Lauritsen, K.; Riley, S. und Lundell, L. (1998): The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease, Scand.J Gastroenterol. 33 [10], Seite 1023-1029.

Chang, C. S.; Poon, S. K.; Lien, H. C. und Chen, G. H. (1997): The incidence of reflux esophagitis among the Chinese, Am.J Gastroenterol. 92 [4], Seite 668-671.

Chiba, N.; De Gara, C. J.; Wilkinson, J. M. und Hunt, R. H. (1997): Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis, Gastroenterology 112 [6], Seite 1798-1810.

Coppola, D. und Karl, R. C. (1999): Barrett's Esophagus and Barrett's Associated Neoplasia: Etiology and Pathologic Features, Cancer Control 6 [1], Seite 21-27.

Crawley, J.; Frank, L.; Joshua-Gotlib, S.; Flynn, J.; Frank, S. und Wiklund, I. (2001): Measuring change in quality of life in response to Helicobacter pylori eradication in peptic ulcer disease: the QOLRAD, Dig.Dis.Sci. 46 [3], Seite 571-580.

de Caestecker, J. (2001): ABC of the upper gastrointestinal tract: Oesophagus: heartburn, BMJ 323 [7315], Seite 736-739.

Dent, J.; Brun, J.; Fendrick, A. M.; Fennerty, M. B.; Janssens, J.; Kahrilas, P. J.; Lauritsen, K.; Reynolds, J. C.; Shaw, M. und Talley, N. J. (1999a): An evidence-based appraisal of reflux disease management --- the Genval Workshop Report, Gut 44 [90002], Seite 1-16. URL: http://gut.bmjjournals.com

Dent, J.; Brun, J.; Fendrick, A. M.; Fennerty, M. B.; Janssens, J.; Kahrilas, P. J.; Lauritsen, K.; Reynolds, J. C.; Shaw, M. und Talley, N. J. (1999b): An evidence-based appraisal of reflux disease management --- the Genval Workshop Report, Gut 44 [90002], Seite 1-16. URL: http://gut.bmjjournals.com

Dent, J.; Brun, J.; Fendrick, A. M.; Fennerty, M. B.; Janssens, J.; Kahrilas, P. J.; Lauritsen, K.; Reynolds, J. C.; Shaw, M. und Talley, N. J. (1999c): An evidence-based appraisal of reflux disease management --- the Genval Workshop Report, Gut 44 [90002], Seite 1-16. URL: http://gut.bmjjournals.com

Dent, J.; Brun, J.; Fendrick, A. M.; Fennerty, M. B.; Janssens, J.; Kahrilas, P. J.; Lauritsen, K.; Reynolds, J. C.; Shaw, M. und Talley, N. J. (1999d): An evidence-based appraisal of reflux disease management --- the Genval Workshop Report, Gut 44 [90002], Seite 1-16. URL: http://gut.bmjjournals.com

Dent, J.; Brun, J.; Fendrick, A. M.; Fennerty, M. B.; Janssens, J.; Kahrilas, P. J.; Lauritsen, K.; Reynolds, J. C.; Shaw, M. und Talley, N. J. (1999e): An evidence-based appraisal of reflux disease management --- the Genval Workshop Report, Gut 44 [90002], Seite 1-16. URL: http://gut.bmjjournals.com

Dent, J.; Brun, J.; Fendrick, A. M.; Fennerty, M. B.; Janssens, J.; Kahrilas, P. J.; Lauritsen, K.; Reynolds, J. C.; Shaw, M. und Talley, N. J. (1999f): An evidence-based appraisal of reflux disease management --- the Genval Workshop Report, Gut 44 [90002], Seite 1-16. URL: http://gut.bmjjournals.com

Dent, J.; El-Serag, H. B.; Wallander, M. A. und Johansson, S. (2005d): Epidemiology of gastro-oesophageal reflux disease: a systematic review, Gut 54 [5], Seite 710-717.

Dent, J.; El-Serag, H. B.; Wallander, M. A. und Johansson, S. (2005c): Epidemiology of gastro-oesophageal reflux disease: a systematic review, Gut 54 [5], Seite 710-717.

Dent, J.; El-Serag, H. B.; Wallander, M. A. und Johansson, S. (2005g): Epidemiology of gastro-oesophageal reflux disease: a systematic review, Gut 54 [5], Seite 710-717.

Dent, J.; El-Serag, H. B.; Wallander, M. A. und Johansson, S. (2005f): Epidemiology of gastro-oesophageal reflux disease: a systematic review, Gut 54 [5], Seite 710-717.

Dent, J.; El-Serag, H. B.; Wallander, M. A. und Johansson, S. (2005e): Epidemiology of gastro-oesophageal reflux disease: a systematic review, Gut 54 [5], Seite 710-717.

Dent, J.; El-Serag, H. B.; Wallander, M. A. und Johansson, S. (2005a): Epidemiology of gastro-oesophageal reflux disease: a systematic review, Gut 54 [5], Seite 710-717.

Dent, J.; El-Serag, H. B.; Wallander, M. A. und Johansson, S. (2005b): Epidemiology of gastro-oesophageal reflux disease: a systematic review, Gut 54 [5], Seite 710-717.

DeVault, K. R. und Castell, D. O. (1999): Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology, Am.J Gastroenterol. 94 [6], Seite 1434-1442.

Dimenas, E. (1993): Methodological aspects of evaluation of Quality of Life in upper gastrointestinal diseases, Scand.J Gastroenterol.Suppl 199:18-21., Seite 18-21.

Dimenas, E.; Carlsson, G.; Glise, H.; Israelsson, B. und Wiklund, I. (1996): Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease, Scand.J.Gastroenterol.Suppl 221:8-13., Seite 8-13.

Eckardt, V. F.; Kanzler, G. und Bernhard, G. (2001): Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation, Am J Med 111 [1], Seite 33-37.

Eisen, Glenn M.; LockeIII, G. Richard und Provenzale, Dawn (1999): Health-related quality of life: a primer for gastroenterologists, The American Journal of Gastroenterology 94 [8], Seite 2017-2021. URL: http://www.sciencedirect.com/science/article/B6VHV-3X3BNHK-B/2/6eb6f8ae6a6b0365b5596033f662c1d8

el Serag, H. B. und Johanson, J. F. (2002): Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease, Scand.J Gastroenterol. 37 [8], Seite 899-904.

Eloubeidi, M. A. und Provenzale, D. (2000): Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus, Am J Gastroenterol. 95 [8], Seite 1881-1887.

Ergun, G. A. und Kahrilas, P. J. (1996): Clinical applications of esophageal manometry and pH monitoring, Am.J Gastroenterol. 91 [6], Seite 1077-1089.

Fass, R.; Ofman, J. J.; Gralnek, I. M.; Johnson, C.; Camargo, E.; Sampliner, R. E. und Fennerty, M. B. (1999): Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease, Archives of Internal Medicine 159 [18], Seite 2161-2168.

Fennerty, M. B. (2003a): The continuum of GERD complications, Cleve.Clin.J Med 70 Suppl 5:S33-50., Seite S33-S50.

Fennerty, M. B. (2003b): The continuum of GERD complications, Cleve.Clin.J Med 70 Suppl 5:S33-50., Seite S33-S50.

Fisher, B. L.; Pennathur, A.; Mutnick, J. L. und Little, A. G. (1999): Obesity correlates with gastroesophageal reflux, Dig.Dis.Sci. 44 [11], Seite 2290-2294.

Fock, K. M.; Talley, N.; Hunt, R.; Fass, R.; Nandurkar, S.; Lam, S. K.; Goh, K. L. und Sollano, J. (2004b): Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease, J Gastroenterol.Hepatol. 19 [4], Seite 357-367.

Fock, K. M.; Talley, N.; Hunt, R.; Fass, R.; Nandurkar, S.; Lam, S. K.; Goh, K. L. und Sollano, J. (2004a): Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease, J Gastroenterol.Hepatol. 19 [4], Seite 357-367.

Fock, K. M.; Talley, N.; Hunt, R.; Fass, R.; Nandurkar, S.; Lam, S. K.; Goh, K. L. und Sollano, J. (2004c): Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease, J Gastroenterol.Hepatol. 19 [4], Seite 357-367.

Fock, K. M.; Talley, N.; Hunt, R.; Fass, R.; Nandurkar, S.; Lam, S. K.; Goh, K. L. und Sollano, J. (2004d): Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease, J Gastroenterol.Hepatol. 19 [4], Seite 357-367.

Fraser-Moodie, C. A.; Norton, B.; Gornall, C.; Magnago, S.; Weale, A. R. und Holmes, G. K. (1999): Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight, Scand.J Gastroenterol. 34 [4], Seite 337-340.

Garrido, Serrano A.; Guerrero Igea, F. J.; Lepe Jimenez, J. A. und Perianes, Hernandez C. (2003): Clinical features and endoscopic progression of gastroesophageal reflux disease, Rev.Esp.Enferm.Dig. 95 [10], Seite 712-11.

Gerards, C.; Peitz, U. und Malfertheiner, P. (2001): [Reflux esophagitis--a community-wide increase in incidence], Ther Umsch. 58 [3], Seite 137-145.

Gerson, L. B.; Robbins, A. S.; Garber, A.; Hornberger, J. und Triadafilopoulos, G. (2000): A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease, Am.J.Gastroenterol. 95 [2], Seite 395-407.

Gerson, L. B.; Shetler, K. und Triadafilopoulos, G. (2002): Prevalence of Barrett's esophagus in asymptomatic individuals, Gastroenterology 123 [2], Seite 461-467.

Gralnek, Ian M. (2001b): Diagnosis and management of gastroesophageal reflux disease in the primary care setting: can health-related quality of life play a role?, The American Journal of Gastroenterology 96 [1], Seite 54-56. URL: http://www.sciencedirect.com/science/article/B6VHV-43P3W58-2Y/2/c0194a0829dccd33769cefabdf64022a

Gralnek, Ian M. (2001a): Diagnosis and management of gastroesophageal reflux disease in the primary care setting: can health-related quality of life play a role?, The American Journal of Gastroenterology 96 [1], Seite 54-56. URL: http://www.sciencedirect.com/science/article/B6VHV-43P3W58-2Y/2/c0194a0829dccd33769cefabdf64022a

Guyatt, G. H.; Feeny, D. H. und Patrick, D. L. (1993): Measuring health-related quality of life, Ann.Intern Med 118 [8], Seite 622-629.

Haque, M.; Wyeth, J. W.; Stace, N. H.; Talley, N. J. und Green, R. (2000): Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study, N Z.Med J 113 [1110], Seite 178-181.

Haringsma, J.; Siersema, P. D. und Kuipers, E. J. (2003): Endoscopic treatment of gastro-oesophageal reflux disease: the new kid on the block, Scand.J Gastroenterol.Suppl [239], Seite 29-33.

Havelund, T.; Lind, T.; Wiklund, I.; Glise, H.; Hernqvist, H.; Lauritsen, K.; Lundell, L.; Pedersen, S. A.; Carlsson, R. und Junghard, O. (1999): Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole, The American Journal of Gastroenterology 94 [7], Seite 1782-1789. URL: http://www.sciencedirect.com/science/article/B6VHV-3WV41T8-K/2/7496cc1fe97ed5cf58aaa81fe6da6d6d

Heading, R. C. (1999): Prevalence of upper gastrointestinal symptoms in the general population: a systematic review, Scand.J Gastroenterol.Suppl 231:3-8., Seite 3-8.

Hetzel, D. J.; Dent, J.; Reed, W. D.; Narielvala, F. M.; Mackinnon, M.; McCarthy, J. H.; Mitchell, B.; Beveridge, B. R.; Laurence, B. H.; Gibson, G. G. und . (1988): Healing and relapse of severe peptic esophagitis after treatment with omeprazole, Gastroenterology 95 [4], Seite 903-912.

Holscher, A. H.; Bollschweiler, E. und Rosch, W. (2004): [Gastroesophageal reflux disease: medical or surgical treatment?], Dtsch.Med Wochenschr. 129 [17], Seite 967-969.

Irvine, E. J. (2004): Quality of life assessment in gastro-oesophageal reflux disease, Gut 53 [suppl_4], Seite iv35-iv39. URL: http://gut.bmjjournals.com/cgi/content/abstract/53/suppl_4/iv35

Jaspersen, D.; Kulig, M.; Labenz, J.; Leodolter, A.; Lind, T.; Meyer-Sabellek, W.; Vieth, M.; Willich, S. N.; Lindner, D.; Stolte, M. und Malfertheiner, P. (2003): Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study, Aliment Pharmacol Ther 17 [12], Seite 1515-1520.

Johanson, J. F. (2000): Epidemiology of esophageal and supraesophageal reflux injuries, Am J Med 108 Suppl 4a:99S-103S., Seite 99S-103S.

Johanson, J. F. (2001b): Critical review of the epidemiology of gastroesophageal reflux disease with specific comparisons to asthma and breast cancer, Am J Gastroenterol. 96 [8 Suppl], Seite S19-S21.

Johanson, J. F. (2001a): Critical review of the epidemiology of gastroesophageal reflux disease with specific comparisons to asthma and breast cancer, Am J Gastroenterol. 96 [8 Suppl], Seite S19-S21.

Jones, R. H.; Lydeard, S. E.; Hobbs, F. D.; Kenkre, J. E.; Williams, E. I.; Jones, S. J.; Repper, J. A.; Caldow, J. L.; Dunwoodie, W. M. und Bottomley, J. M. (1990): Dyspepsia in England and Scotland, Gut 31 [4], Seite 401-405.

Kahrilas, P. J. (2003e): GERD pathogenesis, pathophysiology, and clinical manifestations, Cleve.Clin.J Med 70 Suppl 5:S4-19., Seite S4-19.

Kahrilas, P. J. (2003d): GERD pathogenesis, pathophysiology, and clinical manifestations, Cleve.Clin.J Med 70 Suppl 5:S4-19., Seite S4-19.

Kahrilas, P. J. (2003b): GERD pathogenesis, pathophysiology, and clinical manifestations, Cleve.Clin.J Med 70 Suppl 5:S4-19., Seite S4-19.

Kahrilas, P. J. (2003a): GERD pathogenesis, pathophysiology, and clinical manifestations, Cleve.Clin.J Med 70 Suppl 5:S4-19., Seite S4-19.

Kahrilas, P. J. (2003c): GERD pathogenesis, pathophysiology, and clinical manifestations, Cleve.Clin.J Med 70 Suppl 5:S4-19., Seite S4-19.

Kaplan-Machlis, B.; Spiegler, G. E. und Revicki, D. A. (1999b): Health-related quality of life in primary care patients with gastroesophageal reflux disease, Ann.Pharmacother. 33 [10], Seite 1032-1036.

Kaplan-Machlis, B.; Spiegler, G. E. und Revicki, D. A. (1999a): Health-related quality of life in primary care patients with gastroesophageal reflux disease, Ann.Pharmacother. 33 [10], Seite 1032-1036.

Kennedy, T. und Jones, R. (2000): The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms, Aliment Pharmacol Ther 14 [12], Seite 1589-1594.

Kirshner, B. und Guyatt, G. (1985): A methodological framework for assessing health indices, J Chronic.Dis. 38 [1], Seite 27-36.

Kjellin, A.; Ramel, S.; Rossner, S. und Thor, K. (1996b): Gastroesophageal reflux in obese patients is not reduced by weight reduction, Scand.J Gastroenterol. 31 [11], Seite 1047-1051.

Kjellin, A.; Ramel, S.; Rossner, S. und Thor, K. (1996a): Gastroesophageal reflux in obese patients is not reduced by weight reduction, Scand.J Gastroenterol. 31 [11], Seite 1047-1051.

Kleinman, L.; Leidy, N. K.; Crawley, J.; Bonomi, A. und Schoenfeld, P. (2001): A comparative trial of paper-and-pencil versus computer administration of the Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire, Med Care 39 [2], Seite 181-189.

Kulich, K. R.; Malfertheiner, P.; Madisch, A.; Labenz, J.; Bayerdorffer, E.; Miehlke, S.; Carlsson, J. und Wiklund, I. K. (2003): Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux disease, Health Qual.Life Outcomes. 1 [1], Seite 62.

Kulig, M.; Leodolter, A.; Vieth, M.; Schulte, E.; Jaspersen, D.; Labenz, J.; Lind, T.; Meyer-Sabellek, W.; Malfertheiner, P.; Stolte, M. und Willich, S. N. (2003c): Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative, Aliment Pharmacol Ther 18 [8], Seite 767-776.

Kulig, M.; Leodolter, A.; Vieth, M.; Schulte, E.; Jaspersen, D.; Labenz, J.; Lind, T.; Meyer-Sabellek, W.; Malfertheiner, P.; Stolte, M. und Willich, S. N. (2003a): Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative, Aliment Pharmacol Ther 18 [8], Seite 767-776.

Kulig, M.; Leodolter, A.; Vieth, M.; Schulte, E.; Jaspersen, D.; Labenz, J.; Lind, T.; Meyer-Sabellek, W.; Malfertheiner, P.; Stolte, M. und Willich, S. N. (2003b): Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative, Aliment Pharmacol Ther 18 [8], Seite 767-776.

Kulig, M.; Nocon, M.; Vieth, M.; Leodolter, A.; Jaspersen, D.; Labenz, J.; Meyer-Sabellek, W.; Stolte, M.; Lind, T.; Malfertheiner, P. und Willich, S. N. (2004a): Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study, J Clin.Epidemiol. 57 [6], Seite 580-589.

Kulig, M.; Nocon, M.; Vieth, M.; Leodolter, A.; Jaspersen, D.; Labenz, J.; Meyer-Sabellek, W.; Stolte, M.; Lind, T.; Malfertheiner, P. und Willich, S. N. (2004b): Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study, J Clin.Epidemiol. 57 [6], Seite 580-589.

Labenz, J.; Jaspersen, D.; Kulig, M.; Leodolter, A.; Lind, T.; Meyer-Sabellek, W.; Stolte, M.; Vieth, M.; Willich, S. und Malfertheiner, P. (2004): Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative, Am.J.Gastroenterol. 99 [9], Seite 1652-1656.

Lagergren, J.; Bergstrom, R. und Nyren, O. (2000a): No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study, Gut 47 [1], Seite 26-29.

Lagergren, J.; Bergstrom, R. und Nyren, O. (2000b): No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study, Gut 47 [1], Seite 26-29.

Levin, T. R.; Schmittdiel, J. A.; Kunz, K.; Henning, J. M.; Henke, C. J.; Colby, C. J. und Selby, J. V. (1997): Costs of acid-related disorders to a health maintenance organization, Am J Med 103 [6], Seite 520-528.

Lieberman, D. A.; Oehlke, M. und Helfand, M. (1997): Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy, Am J Gastroenterol. 92 [8], Seite 1293-1297.

Lind, T.; Havelund, T.; Carlsson, R.; Anker-Hansen, O.; Glise, H.; Hernqvist, H.; Junghard, O.; Lauritsen, K.; Lundell, L.; Pedersen, S. A. und Stubberod, A. (1997b): Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response, Scand.J Gastroenterol. 32 [10], Seite 974-979.

Lind, T.; Havelund, T.; Carlsson, R.; Anker-Hansen, O.; Glise, H.; Hernqvist, H.; Junghard, O.; Lauritsen, K.; Lundell, L.; Pedersen, S. A. und Stubberod, A. (1997c): Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response, Scand.J Gastroenterol. 32 [10], Seite 974-979.

Lind, T.; Havelund, T.; Carlsson, R.; Anker-Hansen, O.; Glise, H.; Hernqvist, H.; Junghard, O.; Lauritsen, K.; Lundell, L.; Pedersen, S. A. und Stubberod, A. (1997a): Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response, Scand.J Gastroenterol. 32 [10], Seite 974-979.

Locke, G. R.; Talley, N. J.; Fett, S. L.; Zinsmeister, A. R. und Melton, L. J. (1999): Risk factors associated with symptoms of gastroesophageal reflux, Am J Med 106 [6], Seite 642-649.

Locke, G. R.; Talley, N. J.; Weaver, A. L. und Zinsmeister, A. R. (1994): A new questionnaire for gastroesophageal reflux disease, Mayo Clin.Proc. 69 [6], Seite 539-547.

Locke, G. R.; Zinsmeister, A. R. und Talley, N. J. (2003b): Can symptoms predict endoscopic findings in GERD?, Gastrointest.Endosc. 58 [5], Seite 661-670.

Locke, G. R.; Zinsmeister, A. R. und Talley, N. J. (2003a): Can symptoms predict endoscopic findings in GERD?, Gastrointest.Endosc. 58 [5], Seite 661-670.

Loffeld, R. J. und van der Putten, A. B. (2003): Rising incidence of reflux oesophagitis in patients undergoing upper gastrointestinal endoscopy, Digestion 68 [2-3], Seite 141-144.

Louis, E.; DeLooze, D.; Deprez, P.; Hiele, M.; Urbain, D.; Pelckmans, P.; Deviere, J. und Deltenre, M. (2002): Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources, Eur.J Gastroenterol.Hepatol. 14 [3], Seite 279-284.

Lundell, L.; Ruth, M.; Sandberg, N. und Bove-Nielsen, M. (1995): Does massive obesity promote abnormal gastroesophageal reflux?, Dig.Dis.Sci. 40 [8], Seite 1632-1635.

Lundell, L. R.; Dent, J.; Bennett, J. R.; Blum, A. L.; Armstrong, D.; Galmiche, J. P.; Johnson, F.; Hongo, M.; Richter, J. E.; Spechler, S. J.; Tytgat, G. N. und Wallin, L. (1999): Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification, Gut 45 [2], Seite 172-180.

Madisch, A.; Kulich, K. R.; Malfertheiner, P.; Ziegler, K.; Bayerdorffer, E.; Miehlke, S.; Labenz, J.; Carlsson, J. und Wiklund, I. K. (2003b): Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany, Z.Gastroenterol. 41 [12], Seite 1137-1143.

Madisch, A.; Kulich, K. R.; Malfertheiner, P.; Ziegler, K.; Bayerdorffer, E.; Miehlke, S.; Labenz, J.; Carlsson, J. und Wiklund, I. K. (2003a): Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany, Z.Gastroenterol. 41 [12], Seite 1137-1143.

Malfertheiner, P.; Lind, T.; Willich, S.; Vieth, M.; Jaspersen, D.; Labenz, J.; Meyer-Sabellek, W.; Junghard, O. und Stolte, M. (2005a): Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study, Gut 54 [6], Seite 746-751.

Malfertheiner, P.; Lind, T.; Willich, S.; Vieth, M.; Jaspersen, D.; Labenz, J.; Meyer-Sabellek, W.; Junghard, O. und Stolte, M. (2005b): Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study, Gut 54 [6], Seite 746-751.

Manterola, C.; Munoz, S.; Grande, L. und Bustos, L. (2002): Initial validation of a questionnaire for detecting gastroesophageal reflux disease in epidemiological settings, J Clin.Epidemiol. 55 [10], Seite 1041-1045.

Moss, S. F.; Armstrong, D.; Arnold, R.; Ferenci, P.; Fock, K. M.; Holtmann, G.; McCarthy, D. M.; Moraes-Filho, J. P.; Mutschler, E.; Playford, R.; Spechler, S. J.; Stanghellini, V. und Modlin, I. M. (2003): GERD 2003 - A Consensus on the Way Ahead, Digestion 67 [3], Seite 111-117.

Muldoon, M. F.; Barger, S. D.; Flory, J. D. und Manuck, S. B. (1998): What are quality of life measurements measuring?, BMJ 316 [7130], Seite 542-545.

Murray, L.; Johnston, B.; Lane, A.; Harvey, I.; Donovan, J.; Nair, P. und Harvey, R. (2003b): Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project, Int.J Epidemiol. 32 [4], Seite 645-650.

Murray, L.; Johnston, B.; Lane, A.; Harvey, I.; Donovan, J.; Nair, P. und Harvey, R. (2003a): Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project, Int.J Epidemiol. 32 [4], Seite 645-650.

Nandurkar, S. und Talley, N. J. (2000b): Epidemiology and natural history of reflux disease, Baillieres Best.Pract.Res.Clin.Gastroenterol. 14 [5], Seite 743-757.

Nandurkar, S. und Talley, N. J. (2000a): Epidemiology and natural history of reflux disease, Baillieres Best.Pract.Res.Clin.Gastroenterol. 14 [5], Seite 743-757.

Nilsson, M.; Johnsen, R.; Ye, W.; Hveem, K. und Lagergren, J. (2004): Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux, Gut 53 [12], Seite 1730-1735.

Nilsson, M.; Johnsen, R.; Ye, W.; Hveem, K. und Lagergren, J. (2004b): Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex, Scand.J.Gastroenterol. 39 [11], Seite 1040-1045.

Nilsson, M.; Johnsen, R.; Ye, W.; Hveem, K. und Lagergren, J. (2003b): Obesity and estrogen as risk factors for gastroesophageal reflux symptoms, JAMA: The Journal of the American Medical Association 290 [1], Seite 66-72.

Nilsson, M.; Johnsen, R.; Ye, W.; Hveem, K. und Lagergren, J. (2004a): Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex, Scand.J.Gastroenterol. 39 [11], Seite 1040-1045.

Nilsson, M.; Johnsen, R.; Ye, W.; Hveem, K. und Lagergren, J. (2003a): Obesity and estrogen as risk factors for gastroesophageal reflux symptoms, JAMA: The Journal of the American Medical Association 290 [1], Seite 66-72.

Nilsson, M.; Johnsen, R.; Ye, W.; Hveem, K. und Lagergren, J. (2003c): Obesity and estrogen as risk factors for gastroesophageal reflux symptoms, JAMA: The Journal of the American Medical Association 290 [1], Seite 66-72.

Nilsson, M.; Lundegardh, G.; Carling, L.; Ye, W. und Lagergren, J. (2002b): Body mass and reflux oesophagitis: an oestrogen-dependent association?, Scand.J Gastroenterol. 37 [6], Seite 626-630.

Nilsson, M.; Lundegardh, G.; Carling, L.; Ye, W. und Lagergren, J. (2002a): Body mass and reflux oesophagitis: an oestrogen-dependent association?, Scand.J Gastroenterol. 37 [6], Seite 626-630.

Nocon, M.; Kulig, M.; Leodolter, A.; Malfertheiner, P. und Willich, S. N. (2005): Validation of the Reflux Disease Questionnaire for a German population, Eur.J.Gastroenterol.Hepatol. 17 [2], Seite 229-233.

Oliveria, Susan A.; Christos, Paul J.; Talley, Nicholas J. und Dannenberg, Andrew J. (1999): Heartburn Risk Factors, Knowledge, and Prevention Strategies: A Population-Based Survey of Individuals With Heartburn, Archives of Internal Medicine 159 [14], Seite 1592-1598. URL: http://archinte.ama-assn.org/cgi/content/abstract/159/14/1592

Pare, P.; Armstrong, D.; Pericak, D. und Pyzyk, M. (2003): Pantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine, J Clin.Gastroenterol. 37 [2], Seite 132-138.

Patrick, D. L. und Deyo, R. A. (1989): Generic and disease-specific measures in assessing health status and quality of life, Med Care 27 [3 Suppl], Seite S217-S232.

Ponce, J.; Arguello, L.; Bastida, G.; Ponce, M.; Ortiz, V. und Garrigues, V. (2004): On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction, Dig.Dis.Sci. 49 [6], Seite 931-936.

Rawlins, M. D. und Culyer, A. J. (2004): National Institute for Clinical Excellence and its value judgments, BMJ 329 [7459], Seite 224-227.

Revicki , Dennis A.; Wood BA, Martha; Maton MD, Paul N. und Sorensen MPH, Sonja (1998b): The Impact of Gastroesophageal Reflux Disease on Health-related Quality of Life, The American Journal of Medicine 104 [3], Seite 252-258. URL: http://www.sciencedirect.com/science/article/B6TDC-3SF0YB6-7/2/d005d95c846edec8aa69fc4385897ed4

Revicki , Dennis A.; Wood BA, Martha; Maton MD, Paul N. und Sorensen MPH, Sonja (1998c): The Impact of Gastroesophageal Reflux Disease on Health-related Quality of Life, The American Journal of Medicine 104 [3], Seite 252-258. URL: http://www.sciencedirect.com/science/article/B6TDC-3SF0YB6-7/2/d005d95c846edec8aa69fc4385897ed4

Revicki , Dennis A.; Wood BA, Martha; Maton MD, Paul N. und Sorensen MPH, Sonja (1998a): The Impact of Gastroesophageal Reflux Disease on Health-related Quality of Life, The American Journal of Medicine 104 [3], Seite 252-258. URL: http://www.sciencedirect.com/science/article/B6TDC-3SF0YB6-7/2/d005d95c846edec8aa69fc4385897ed4

Richter, J. (1999): Do we know the cause of reflux disease?, Eur.J Gastroenterol.Hepatol. 11 Suppl 1:S3-9., Seite S3-S9.

Richter, J. E. (2003b): Diagnostic tests for gastroesophageal reflux disease, Am.J Med Sci. 326 [5], Seite 300-308.

Richter, J. E. (2003a): Diagnostic tests for gastroesophageal reflux disease, Am.J Med Sci. 326 [5], Seite 300-308.

Ruhl, C. E. und Everhart, J. E. (1999): Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I Epidemiologic Followup Study. First National Health and Nutrition Examination Survey, Ann Epidemiol. 9 [7], Seite 424-435.

Sanders, C.; Egger, M.; Donovan, J.; Tallon, D. und Frankel, S. (1998): Reporting on quality of life in randomised controlled trials: bibliographic study, BMJ 317 [7167], Seite 1191-1194.

Sandler, Robert; Everhart, J. E.; Donowitz, Mark; Adams, Elizabeth; Cronin, Kelly; Goodman, Clifford; Gemmen, Eric; Shah, Shefali; Avdic, Aida und Rubin, Robert (2002): The burden of selected digestive diseases in the United States, Gastroenterology 122 [5], Seite 1500-1511. URL: http://www.gastro.org/scripts/om.dll/serve?article=a0050201500

Savarino, V. und Dulbecco, P. (2004): Optimizing symptom relief and preventing complications in adults with gastro-oesophageal reflux disease, Digestion 69 Suppl 1:9-16., Seite 9-16.

Schwenkglenks, M.; Marbet, U. A. und Szucs, T. D. (2004): Epidemiology and costs of gastroesophageal reflux disease in Switzerland: a population-based study, Soz.Praventivmed. 49 [1], Seite 51-61.

Shaheen, N. und Provenzale, D. (2003c): The epidemiology of gastroesophageal reflux disease, Am.J Med Sci. 326 [5], Seite 264-273.

Shaheen, N. und Provenzale, D. (2003b): The epidemiology of gastroesophageal reflux disease, Am.J Med Sci. 326 [5], Seite 264-273.

Shaheen, N. und Provenzale, D. (2003a): The epidemiology of gastroesophageal reflux disease, Am.J Med Sci. 326 [5], Seite 264-273.

Shaheen, Nicholas (2002): Is there a "Barrett's iceberg?", Gastroenterology 123 [2], Seite 636-639. URL: http://www.gastro.org/scripts/om.dll/serve?article=agast1230636

Shaheen, Nicholas; Crosby, Melissa; Bozymski, Eugene und Sandler, Robert (2000): Is there publication bias in the reporting of cancer risk in Barrett's esophagus?, Gastroenterology 119 [2], Seite 333-338. URL: http://www.gastro.org/scripts/om.dll/serve?article=a0020000333

Shaw, M. J.; Talley, N. J.; Beebe, T. J.; Rockwood, T.; Carlsson, R.; Adlis, S.; Fendrick, A. M.; Jones, R.; Dent, J. und Bytzer, P. (2001b): Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease, Am.J Gastroenterol. 96 [1], Seite 52-57.

Shaw, M. J.; Talley, N. J.; Beebe, T. J.; Rockwood, T.; Carlsson, R.; Adlis, S.; Fendrick, A. M.; Jones, R.; Dent, J. und Bytzer, P. (2001a): Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease, Am.J Gastroenterol. 96 [1], Seite 52-57.

Sherbourne, C. D.; Sturm, R. und Wells, K. B. (1999): What outcomes matter to patients?, J Gen.Intern Med 14 [6], Seite 357-363.

Sonnenberg, A. und el Serag, H. B. (1999): Clinical epidemiology and natural history of gastroesophageal reflux disease, Yale J Biol.Med 72 [2-3], Seite 81-92.

Spechler, S. J. (2003): Medical or invasive therapy for GERD: an acidulous analysis, Clin.Gastroenterol.Hepatol. 1 [2], Seite 81-88.

Stanghellini, V. (1999): Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST), Scand.J Gastroenterol.Suppl 231:20-8., Seite 20-28.

Stanghellini, V.; Armstrong, D.; Monnikes, H. und Bardhan, K. D. (2004): Do we need a new gastro-oesophageal reflux disease questionnaire?, Aliment Pharmacol Ther. 19 [5], Seite 463-479.

Talley, N. J.; Howell, S. und Poulton, R. (2004): Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study, Am.J.Gastroenterol. 99 [9], Seite 1807-1814.

Valle, C.; Broglia, F.; Pistorio, A.; Tinelli, C. und Perego, M. (1999): Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease, Dig.Dis.Sci. 44 [9], Seite 1848-1852.

van Herwaarden, M. A. und Smout, A. J. (2000): Diagnosis of reflux disease, Baillieres Best.Pract.Res.Clin.Gastroenterol. 14 [5], Seite 759-774.

Velanovich, V. (1998): Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease, J.Gastrointest.Surg. 2 [2], Seite 141-145.

Velanovich, V. (2000): Quality of life and severity of symptoms in gastro-oesophageal reflux disease: a clinical review, Eur.J.Surg. 166 [7], Seite 516-525.

Velanovich, V.; Vallance, S. R.; Gusz, J. R.; Tapia, F. V. und Harkabus, M. A. (1996): Quality of life scale for gastroesophageal reflux disease, J Am Coll.Surg. 183 [3], Seite 217-224.

Venables, T. L.; Newland, R. D.; Patel, A. C.; Hole, J.; Wilcock, C. und Turbitt, M. L. (1997): Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice, Scand.J Gastroenterol. 32 [10], Seite 965-973.

Voutilainen, M.; Sipponen, P.; Mecklin, J. P.; Juhola, M. und Farkkila, M. (2000): Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms, Digestion 61 [1], Seite 6-13.

Ware, J. E. und Sherbourne, C. D. (1992b): The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection, Med Care 30 [6], Seite 473-483.

Ware, J. E. und Sherbourne, C. D. (1992a): The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection, Med Care 30 [6], Seite 473-483.

Ware, J. E.; Snow, K. K. und Kosinski, M. (1993): SF-36 Health Survey. Manual and Interpretation Guide, Boston.

Wiebe, Samuel; Guyatt, Gordon; Weaver, Bruce; Matijevic, Suzan und Sidwell, Casey (2003): Comparative responsiveness of generic and specific quality-of-life instruments, Journal of Clinical Epidemiology 56 [1], Seite 52-60. URL: http://www.sciencedirect.com/science/article/B6T84-47W911G-7/2/8c5760d32224dbda16ba3989ce715bdc

Wiklund, I. K.; Junghard, O.; Grace, E.; Talley, N. J.; Kamm, M.; Veldhuyzen, van Zanten; Pare, P.; Chiba, N.; Leddin, D. S.; Bigard, M. A.; Colin, R. und Schoenfeld, P. (1998): Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD), Eur.J Surg.Suppl [583], Seite 41-49.

Wiklund, Ingela (2001c): Quality of life in patients with gastroesophageal reflux disease, The American Journal of Gastroenterology 96 [1], Seite 46-53. URL: http://www.sciencedirect.com/science/article/B6VHV-43P3W58-2X/2/8380ba2cc2e0e2e1e6706ace3973a1ce

Wiklund, Ingela (2001d): Quality of life in patients with gastroesophageal reflux disease, The American Journal of Gastroenterology 96 [1], Seite 46-53. URL: http://www.sciencedirect.com/science/article/B6VHV-43P3W58-2X/2/8380ba2cc2e0e2e1e6706ace3973a1ce

Wiklund, Ingela (2001a): Quality of life in patients with gastroesophageal reflux disease, The American Journal of Gastroenterology 96 [1], Seite 46-53. URL: http://www.sciencedirect.com/science/article/B6VHV-43P3W58-2X/2/8380ba2cc2e0e2e1e6706ace3973a1ce

Wiklund, Ingela (2001b): Quality of life in patients with gastroesophageal reflux disease, The American Journal of Gastroenterology 96 [1], Seite 46-53. URL: http://www.sciencedirect.com/science/article/B6VHV-43P3W58-2X/2/8380ba2cc2e0e2e1e6706ace3973a1ce

Wilson, L. J.; Ma, W. und Hirschowitz, B. I. (1999): Association of obesity with hiatal hernia and esophagitis, Am J Gastroenterol. 94 [10], Seite 2840-2844.

Wong, W. M.; Lai, K. C.; Lam, K. F.; Hui, W. M.; Hu, W. H.; Lam, C. L.; Xia, H. H.; Huang, J. Q.; Chan, C. K.; Lam, S. K. und Wong, B. C. (2003): Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study, Aliment Pharmacol Ther 18 [6], Seite 595-604.

Yacavone, Robert F.; Locke, G. Richard; Provenzale, Dawn T. und Eisen, Glenn M. (2001): Quality of life measurement in gastroenterology: what is available?, The American Journal of Gastroenterology 96 [2], Seite 285-297. URL: http://www.blackwell-synergy.com/links/doi/10.1111/j.1572-0241.2001.03509.x/abs

Yeh, C.; Hsu, C. T.; Ho, A. S.; Sampliner, R. E. und Fass, R. (1997): Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected, Dig.Dis.Sci. 42 [4], Seite 702-706.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
XDiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
23.05.2006